Phage-based antibacterial treatments
Treatments target bacterial infections in humans, particularly infections resistant to antibiotics.
Source: LinkedIn company description · Retrieved October 13, 2026
Pherecydes Pharma develops phage-based antibacterial treatments for human bacterial infections.
Its precision phagotherapy concept treats each patient according to phage activity against the infection-causing bacterial strain. Some of its patented phages have been administered in compassionate treatments in France under French health-authority supervision.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
Treatments target bacterial infections in humans, particularly infections resistant to antibiotics.
Source: LinkedIn company description · Retrieved October 13, 2026
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
Positions describe ordering within each source list. See how lists are built ↗
Embeddable award for your website
Snapshot: September 18, 2026
RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 4, 2026. Directory positions use company-contact counts from separate saved list snapshots dated September 18, 2026 and September 19, 2026. How the company lists are built.
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
Explore more companies by name, headquarters and business focus.